Intravenous gentamicin therapy for infections in patients with cancer.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000150:complications / Q000188:drug therapy*; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy*; D001806:Blood Urea Nitrogen; D002228:Carbenicillin / Q000627:therapeutic use; D002277:Carcinoma / Q000150:complications; D002648:Child; D004357:Drug Synergism; D004432:Ear, Middle / Q000187:drug effects; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D005839:Gentamicins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D007668:Kidney / Q000187:drug effects; D007938:Leukemia / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D009504:Neutrophils / Q000187:drug effects; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D012769:Shock; D013921:Thrombocytopenia / Q000188:drug therapy
D005839:Gentamicins; D002228:Carbenicillin